5517 Results

People

  1. O'Reilly
    O'Reilly
  2. Scheinberg
    Scheinberg
  3. Levine
    Levine
  4. Cheung
    Cheung
  5. Hricak
    Hricak
  6. Massague
    Massague
  7. Lewis
    Lewis
  8. Kernan
    Kernan
  9. Rudin
    Rudin
  10. Rajadhyaksha
    Rajadhyaksha

Groups

  1. Center for Molecular Imaging and Biotechnology (5517)
  2. GSK Faculty (5319)
  3. Sloan Kettering Institute Faculty (3448)
  4. Tow Center for Developmental Oncology (TCDO) (2542)
  5. Department of Medicine (2440)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1825)
  7. Center for Hematologic Malignancies (1694)
  8. Sloan Kettering Institute Postdocs (1657)
  9. Hematologic Malignancies, Division of (1367)
  10. Molecular Pharmacology and Chemistry Program Faculty (1341)
  1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (3380)
  2. Meeting Abstract (1548)
  3. Review (164)
  4. Conference Paper (128)
  5. Book Section (124)
  6. Editorial (107)
  7. Research Letter (27)
  8. Miscellaneous (14)
  9. Book Whole (11)
  10. Guidelines (9)
  11. Correspondence (5)
Groups
  1. Center for Molecular Imaging and Biotechnology (5517)
  2. GSK Faculty (5319)
  3. Sloan Kettering Institute Faculty (3448)
  4. Tow Center for Developmental Oncology (TCDO) (2542)
  5. Department of Medicine (2440)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1825)

More Groups

People
  1. Richard O'Reilly (662)
  2. David Scheinberg (445)
  3. Ross Levine (432)
  4. Nai-Kong Cheung (419)
  5. Hedvig Hricak (387)
  6. Joan Massague (351)

More People

Years
  1. 2025 (1)
  2. 2024 (150)
  3. 2023 (248)
  4. 2022 (308)
  5. 2021 (289)
  6. 2020 (331)

More Years

Publications
  1. Blood (632)
  2. Cancer Research (190)
  3. Journal of Clinical Oncology (170)
  4. Journal of Nuclear Medicine (139)
  5. Biology of Blood and Marrow Transplantation (101)
  6. Proceedings of the National Academy of Sciences of the United States of America (95)

More Publications

Publishers
  1. American Society of Hematology (662)
  2. Nature Publishing Group (527)
  3. Elsevier Inc. (454)
  4. American Association for Cancer Research (369)
  5. Cell Press (355)
  6. Springer (202)

More Publishers

Results (5517)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High-dose naxitamab (humanized-3F8) PLUS stepped-up dosing of granulocyte-macrophage colony-stimulating factor for neuroblastoma: Outpatient treament low immunogenicity, and major responses in a phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for relapsed neuroblastoma resistant to salvage therapy: A phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for consolidating >= 2nd complete remission of high-risk neuroblastoma
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Clinical impact of ALK mutations in neuroblastoma
    Meeting Abstract

    O'Donohue, T.; Gulati, N.; Shukla, N.; Roberts, S.; Basu, E.; Kushner, B.; Cheung, N. K.; Modak, S.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Prognostic significance of ATRX aberrations in neuroblastoma
    Meeting Abstract

    Miltiadous, O.; Kushner, B.; Cheung, N. K.; Shukla, N.; Modak, S.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of "HITS" pilot/phase II study
    Meeting Abstract

    Modak, S.; Kushner, B.; Flores, M.; Santa-Maria, V.; Garraus, M.; Basu, E.; Roberts, S.; Castaneda, A.; Gorostegui, M.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • CAR T-cells followed by CD34-selected T-cell depleted (TCD) ALLO-HSCT is associated with low toxicity and favorable overall survival
    Meeting Abstract

    Fabrizio, V.; Boulad, F.; Cancio, M.; Margossian, S.; Mauguen, A.; Prockop, S.; Scaradavou, M.; Shah, N.; Spitzer, B.; Stieglitz, E.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Phase I study of OKT3 x hu3F8 bispecific antibody (GD2Bi) armed T cells (GD2BATs) in GD2-positive tumors
    Meeting Abstract

    Yankelevich, M.; Modak, S.; Chu, R.; Lee, D. W.; Thakur, A.; Cheung, N. K. V.; Lum, L. G.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Therapeutic implications of a novel driver classification system for cutaneous and unknown primary melanomas
    Meeting Abstract

    Shoushtari, A. N.; Sanchez-Vega, F.; Kantheti, H.; Callahan, M. K.; Postow, M. A.; Barker, C. A.; Chatila, W. K.; Jonsson, P.; Ariyan, C. E.; Brady, M. S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Preliminary results of HITS pilot/phase II study
    Meeting Abstract

    Mora, J.; Kushner, B. H.; Flores, M. A.; Santa-Maria, V.; Garraus, M.; Basu, E. M.; Roberts, S. S.; Castaneda, A.; Gorostegui, M.; Cheung, N. K. V.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save